ANPC AnPac Bio-Medical Science Co., Ltd. ADRs of Class A

Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$0.16
As of 10/05/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  01/30/2020
Outstanding shares:  36,487,245
Average volume:  699,450
Market cap:   $5,859,852
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.69
PS ratio:   1.53
Return on equity:   30,582.61%
Net income %:   -387.96%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy